315 related articles for article (PubMed ID: 8482334)
1. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
[TBL] [Abstract][Full Text] [Related]
2. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
Omata-Yamada T; Yamada H; Lengyel P
J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
[TBL] [Abstract][Full Text] [Related]
3. Increased cell-substrate adhesion accompanies conditional reversion to the normal phenotype in ras-oncogene-transformed NIH-3T3 cells.
Shumaker DK; Sklar MD; Prochownik EV; Varani J
Exp Cell Res; 1994 Oct; 214(2):440-6. PubMed ID: 7925639
[TBL] [Abstract][Full Text] [Related]
4. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
5. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
6. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo onco-suppressor activity of normal cells on cells transformed with the H-ras1 oncogene.
Kakkanas A; Spandidos DA
In Vivo; 1990; 4(2):109-14. PubMed ID: 2129801
[TBL] [Abstract][Full Text] [Related]
8. Thy-1 as a negative growth regulator in ras-transformed mouse fibroblasts.
Sugimoto Y; Ikawa Y; Nakauchi H
Cancer Res; 1991 Jan; 51(1):99-104. PubMed ID: 1670996
[TBL] [Abstract][Full Text] [Related]
9. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
Kivinen L; Pitkänen K; Laiho M
Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
[TBL] [Abstract][Full Text] [Related]
10. trans-Dominant suppressor mutations of the H-ras oncogene.
Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
[TBL] [Abstract][Full Text] [Related]
11. Decreased retinoylation in NIH 3T3 cells transformed with activated Ha-ras.
Takahashi N; De Luca LM; Breitman TR
Biochem Biophys Res Commun; 1997 Oct; 239(1):80-4. PubMed ID: 9345273
[TBL] [Abstract][Full Text] [Related]
12. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene.
Dartsch PC; Ritter M; Häussinger D; Lang F
Eur J Cell Biol; 1994 Apr; 63(2):316-25. PubMed ID: 8082656
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics.
Ji H; Moritz RL; Kim YS; Zhu HJ; Simpson RJ
Electrophoresis; 2007 Jun; 28(12):1997-2008. PubMed ID: 17526045
[TBL] [Abstract][Full Text] [Related]
14. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
Jiang K; Delarue FL; Sebti SM
Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
16. Increased radiation resistance in transformed and nontransformed cells with elevated ras proto-oncogene expression.
Samid D; Miller AC; Rimoldi D; Gafner J; Clark EP
Radiat Res; 1991 May; 126(2):244-50. PubMed ID: 2023995
[TBL] [Abstract][Full Text] [Related]
17. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
Xin H; Geng Y; Pramanik R; Choubey D
J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
[TBL] [Abstract][Full Text] [Related]
18. C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growth.
Guerrero C; Martín-Encabo S; Fernández-Medarde A; Santos E
Oncogene; 2004 Jun; 23(28):4885-93. PubMed ID: 15077165
[TBL] [Abstract][Full Text] [Related]
19. p21ras independent down-regulation of ras-induced increases in natural antibody binding during tumor progression.
Tough DF; Feng X; Chow DA
Nat Immun; 1995; 14(1):20-34. PubMed ID: 7599459
[TBL] [Abstract][Full Text] [Related]
20. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
Shantz LM; Pegg AE
Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
